TERT and thyroid gland carcinoma: Additionally, several studies performed in European (15), Asian (16) and in North American populations (10) have suggested that the co-occurrence of TERT promoter mutations and BRAF V600E or RAS mutations contributes to the progression of thyroid cancer and, therefore, have great value in indicating a worse outcome (12, 13, 17–22).